A revolutionary therapeutic approach for psoriasis: bispecific biological agents

  • Expert Opin Investig Drugs. 2016 Jul;25(7):751-4. doi: 10.1080/13543784.2016.1187130.
T Torres  1 ,  M Romanelli  2 ,  A Chiricozzi  2
Affiliations
  • 1. a Department of Dermatology, Centro Hospitalar do Porto and Instituto de Ciências Biomédicas Abel Salazar , University of Porto , Porto , Portugal.
  • 2. b Dermatology Department , University of Pisa , Pisa , Italy.
PMID: 27153320 DOI: 10.1080/13543784.2016.1187130
Keywords
ABT-122; ALX-0761; AZ17; Bimekizumab; COVA322; Psoriasis; bispecific antibodies.
Products